Most recent articles by:

Richard B. Newman

Richard B. Newman is an Internet Lawyer at Hinch Newman LLP focusing on advertising law, Internet marketing compliance, regulatory defense and digital media matters. His practice involves conducting legal compliance reviews of advertising campaigns across all media channels, regularly representing clients in high-profile investigative proceedings and enforcement actions brought by the Federal Trade Commission and state attorneys general throughout the country, advertising and marketing litigation, advising on email and telemarketing best practice protocol implementation, counseling on eCommerce guidelines and promotional marketing programs, and negotiating and drafting legal agreements.

Lead Generation Platform Developer TCPA Liability Considerations

As previously blogged about here, software developers that are engaged to design lead generation management platforms for third-party use in conjunction with...

FTC Alleges App Developer Violated COPPA by Allowing Ad Networks to Collect PI of Child-Directed Users

The Federal Trade Commission has announced that a developer of apps that are popular with children has agreed to pay $150,000 and...

Payment Processor and Executive to Pay Millions to Settle FTC Allegations of Assisting in Fraudulent Schemes and Credit Card Laundering

According to the Federal Trade Commission, one of the world’s leading payment processing companies and its former executive will pay more than...

FTC Sends More Letters Warning Marketers to Stop Making Unsupported COVID-19 Prevention Claims

The Federal Trade Commission announced it has sent 45 warning letters to marketers about  unsubstantiated claims that their products and therapies can...

Immunity Supplement Marketers Face Heightened Regulatory Scrutiny

Immunity supplements and express or implied COVID-19 prevention, treatment, cure or diagnosis-related representations are squarely within the crosshairs. Without limitation, a lack of competent and reliable scientific evidence with respect to the final product formulation - not just a single/handful of ingredient(s) - could prove disastrous for those hurriedly seeking to bring products to market without first ensuring that lawfully adequate substantiation is possessed prior to dissemination of claims.

Does Coronavirus Excuse Non-Performance Under a Contract?

The Coronavirus outbreak has raised a number of issues relating to contractual performance obligations. An excuse for non-performance of contractual obligations may...

State Attorneys General Ask FTC to Increase Negative Option Marketing Enforcement

A coalition of twenty-three state attorneys general, led by New York AG Letitia James and Pennsylvania AG Josh Shapiro, recently submitted a...

Legal: California Governor Passes Data Broker Registration Law

If compliance with the California Consumer Privacy Act isn’t enough to fill marketers’ compliance plates, California Governor Gavin Newsome has signed a...

Must read

Diversifying Media Mixes: A Surprising Solution to Data Acquisition

As the world becomes increasingly digital, businesses...

Impact.com Hires Talent-Whisperer Michelle Denman as CPO

Impact.com, the world's leading partnership management platform,...

Tal Klein: The Wizard of Digital Engagement

In the age of digital marketing, it's...